Steward Partners Investment Advisory, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$74,845
-38.8%
2,367
-21.0%
0.00%
-50.0%
Q2 2023$122,218
+22.1%
2,997
+11.6%
0.00%0.0%
Q1 2023$100,107
+36.9%
2,686
+28.1%
0.00%
+100.0%
Q4 2022$73,129
-45.4%
2,096
-12.2%
0.00%
-66.7%
Q3 2022$134,000
+8.9%
2,386
+0.8%
0.00%
+50.0%
Q2 2022$123,000
-21.2%
2,368
+10.2%
0.00%0.0%
Q1 2022$156,000
-24.3%
2,148
+23.2%
0.00%
-33.3%
Q4 2021$206,000
-13.4%
1,743
-1.6%
0.00%
-25.0%
Q3 2021$238,000
-19.9%
1,772
-3.4%
0.00%
-20.0%
Q2 2021$297,000
-99.9%
1,834
-35.8%
0.01%
+150.0%
Q1 2021$229,208,000
+1432450.0%
2,856
+861.6%
0.00%
Q4 2020$16,000
+300.0%
297
-25.8%
0.00%
Q1 2020$4,000
-69.2%
400
-55.6%
0.00%
Q4 2019$13,000
+8.3%
9000.0%0.00%
Q3 2019$12,000
+100.0%
900
+125.0%
0.00%
Q2 2019$6,000
-45.5%
4000.0%0.00%
-100.0%
Q3 2018$11,0004000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders